P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

Bibliografski detalji
Glavni autori:	Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath
Format:	Članak
Jezik:	English
Izdano:	Wiley 2023-08-01
Serija:	HemaSphere
Online pristup:	http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2

Slični predmeti

Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
od: Sikander Ailawadhi, i dr.
Izdano: (2024-11-01)

Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
od: Hans C. Lee, i dr.
Izdano: (2021-07-01)

Connect MM Registry as a national reference for United States multiple myeloma patients
od: Sikander Ailawadhi, i dr.
Izdano: (2020-01-01)

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
od: Sundar Jagannath, i dr.
Izdano: (2018-07-01)

Lenalidomide-Associated ITP
od: Christina I. Herold, i dr.
Izdano: (2011-01-01)

Porche 915 1969-76 autobook/
od: 206830 Ball, Kenneth
Izdano: (1978)

Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
od: María-Victoria Mateos, i dr.
Izdano: (2017-10-01)

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
od: Lee, HC, i dr.
Izdano: (2024)

9.15 Biochemistry and Pharmacology of Synaptic Transmission, Fall 2001
od: Wurtman, Richard J., 1936-
Izdano: (2001)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
od: S. A. Tuchman, i dr.
Izdano: (2012-01-01)

Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma
od: C. Cerchione, i dr.
Izdano: (2020-10-01)

P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY
od: A. Oriol, i dr.
Izdano: (2022-06-01)

P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)
od: S. Usmani, i dr.
Izdano: (2022-06-01)

9.15 / 9.150 Biochemistry and Pharmacology of Synaptic Transmission, Fall 2003
od: Wurtman, Richard J., 1936-
Izdano: (2003)

915 nm pumping kilowatt fiber oscillator with high optical-to-optical efficiency
od: Xin Chen, i dr.
Izdano: (2024-11-01)

A new 915 MHz coaxial-line-based microwave plasma source
od: Robert Miotk, i dr.
Izdano: (2024-07-01)

Optimal Ate Pairing on Elliptic Curves with Embedding Degree $9,15$ and $27$
od: Emmanuel Fouotsa, i dr.
Izdano: (2020-04-01)

915 MHz microwave-assisted laparoscopic partial splenectomy: A case series
od: Qiyi Zhang, i dr.
Izdano: (2020-01-01)

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
od: Ajai Chari, i dr.
Izdano: (2017-08-01)

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
od: Seunghee Kim-Schulze, i dr.
Izdano: (2024-04-01)

ARTÍCULO 915 DEL CÓDIGO CIVIL: UNA SOLUCIÓN JURISPRUDENCIAL A LA LIMITACIÓN DE LAS ACCIONES TRADICIONALES Article 915 of the civil code: a jurisprudential solution to the limitation of the traditional actions
od: Arturo Selman Nahum
Izdano: (2011-01-01)

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)
od: Anna Kalff, i dr.
Izdano: (2021-09-01)

Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4
od: Doris K. Hansen, i dr.
Izdano: (2024-08-01)

Coseismic slip and afterslip of the Great Mw 9.15 Sumatra-Andaman earthquake of 2004
od: Chlieh, Mohamed, i dr.
Izdano: (2012)

Measurements and Models of 915 MHz LoRa Radio Propagation in an Underground Gold Mine
od: Philip Branch
Izdano: (2022-11-01)

Analysis of Asphericity and Corneal Longitudinal Spherical Aberration of 915 Chinese Myopic Adult Eyes
od: Zhang J, i dr.
Izdano: (2023-02-01)

Surface energy arising from the behavior of lipid molecules in the water via Γ-convergence
od: Luca Lussardi, i dr.
Izdano: (2013-01-01)

P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
od: R. M. Rifkin, i dr.
Izdano: (2022-06-01)

Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone
od: Karthik Ramasamy, i dr.
Izdano: (2024-02-01)

Atmospheric pressure microwave (915 MHz) plasma for hydrogen production from steam reforming of ethanol
od: Robert Miotk, i dr.
Izdano: (2024-06-01)

Optimization of Nd-Doped LMA Fibers for High-Power Laser Emission Near 915 nm
od: Raphael Florentin, i dr.
Izdano: (2024-01-01)

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients
od: Elisa Rumi, i dr.
Izdano: (2011-03-01)

The use of data from 915 MHz profilers in analysis of ozone episodes in San Diego, California
od: Virginia J. Bigler-Engler, i dr.
Izdano: (1998-12-01)

Hydrogen production by the steam reforming of synthetic biogas in atmospheric-pressure microwave (915 MHz) plasma
od: Bartosz Hrycak, i dr.
Izdano: (2023-02-01)

Potential of Sub-GHz Wireless for Future IoT Wearables and Design of Compact 915 MHz Antenna
od: Adolfo Di Serio, i dr.
Izdano: (2017-12-01)

A Small 915MHz Receiving Antenna for Wireless Power Transmission Aimed at Medical Applications
od: Toshihiro Kumagai, i dr.
Izdano: (2014-01-01)

Therapy of Angiosarcoma with Thalidomide and Lenalidomide
od: M. Jules Mattes, i dr.
Izdano: (2021-11-01)

Impact of ixazomib‐lenalidomide‐dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging‐markets subgroup of the TOURMALINE‐MM1 trial
od: Andrew Spencer, i dr.
Izdano: (2022-11-01)

LENALIDOMIDE RETREATMENT IN A PATIENT WITH RELAPSED MULTIPLE MYELOMA WHO HAD PREVIOUSLY RESPONDED TO LENALIDOMIDE
od: Vincenzo Federico
Izdano: (2014-08-01)

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
od: James L. Rubenstein, i dr.
Izdano: (2018-07-01)